Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C15H15FIN3O3.ClH |
Molecular Weight | 467.662 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.OC[C@@H](O)CNC(=O)C1=C(NC2=C(F)C=C(I)C=C2)C=NC=C1
InChI
InChIKey=HIEXZUXKTABHCP-PPHPATTJSA-N
InChI=1S/C15H15FIN3O3.ClH/c16-12-5-9(17)1-2-13(12)20-14-7-18-4-3-11(14)15(23)19-6-10(22)8-21;/h1-5,7,10,20-22H,6,8H2,(H,19,23);1H/t10-;/m0./s1
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C15H15FIN3O3 |
Molecular Weight | 431.2008 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 02:07:57 UTC 2023
by
admin
on
Sat Dec 16 02:07:57 UTC 2023
|
Record UNII |
6GS1ULF5HV
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
297909
Created by
admin on Sat Dec 16 02:07:57 UTC 2023 , Edited by admin on Sat Dec 16 02:07:57 UTC 2023
|
||
|
FDA ORPHAN DRUG |
328110
Created by
admin on Sat Dec 16 02:07:57 UTC 2023 , Edited by admin on Sat Dec 16 02:07:57 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/10/824
Created by
admin on Sat Dec 16 02:07:57 UTC 2023 , Edited by admin on Sat Dec 16 02:07:57 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
52918382
Created by
admin on Sat Dec 16 02:07:57 UTC 2023 , Edited by admin on Sat Dec 16 02:07:57 UTC 2023
|
PRIMARY | |||
|
EU/3/09/685(POSITIVE)
Created by
admin on Sat Dec 16 02:07:57 UTC 2023 , Edited by admin on Sat Dec 16 02:07:57 UTC 2023
|
PRIMARY | Treatment of pancreatic cancer 8/10/2009 Positive | ||
|
EU/3/10/824 (POSITIVE)
Created by
admin on Sat Dec 16 02:07:57 UTC 2023 , Edited by admin on Sat Dec 16 02:07:57 UTC 2023
|
PRIMARY | Treatment of acute myeloid leukaemia 17/12/2010 Positive | ||
|
DTXSID60154058
Created by
admin on Sat Dec 16 02:07:57 UTC 2023 , Edited by admin on Sat Dec 16 02:07:57 UTC 2023
|
PRIMARY | |||
|
ZZ-117
Created by
admin on Sat Dec 16 02:07:57 UTC 2023 , Edited by admin on Sat Dec 16 02:07:57 UTC 2023
|
PRIMARY | |||
|
1236361-78-6
Created by
admin on Sat Dec 16 02:07:57 UTC 2023 , Edited by admin on Sat Dec 16 02:07:57 UTC 2023
|
PRIMARY | |||
|
100000155425
Created by
admin on Sat Dec 16 02:07:57 UTC 2023 , Edited by admin on Sat Dec 16 02:07:57 UTC 2023
|
PRIMARY | |||
|
SUB129490
Created by
admin on Sat Dec 16 02:07:57 UTC 2023 , Edited by admin on Sat Dec 16 02:07:57 UTC 2023
|
PRIMARY | |||
|
C166935
Created by
admin on Sat Dec 16 02:07:57 UTC 2023 , Edited by admin on Sat Dec 16 02:07:57 UTC 2023
|
PRIMARY | |||
|
6GS1ULF5HV
Created by
admin on Sat Dec 16 02:07:57 UTC 2023 , Edited by admin on Sat Dec 16 02:07:57 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |